(MedPage Today) — An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney disease (CKD) and type 2 diabetes…
Source link : https://www.medpagetoday.com/meetingcoverage/era/115931
Author :
Publish date : 2025-06-05 20:53:00
Copyright for syndicated content belongs to the linked Source.
